Ferinject 50 mg/ 500 mg Solution for injection/infusion.
PDF Leaflet Revision Date: 28 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of iron deficiency in adults when oral iron is ineffective or cannot be used.
Dosage (summary)
Individualized based on body weight and Hb level; max 1000 mg/week.
Special Populations
- Elderly
- Haemodialysis-dependent chronic kidney disease
Pregnancy & Breastfeeding
Use in pregnancy only if necessary; limited data available. Safety in lactation not established.
Key Drug Interactions
- Reduced absorption of oral iron if given within 5 days of parenteral iron
Contraindications
- Hypersensitivity to ferric carboxymaltose
- Non-iron deficiency anemia
- Iron overload
Common side effects
- Nausea
- Injection site reactions
- Hypophosphataemia
- Headache
- Flushing
Counselling Points
- Monitor for allergic reactions
- Avoid mixing with other medications
- Report any unusual symptoms immediately
Serious warnings
- Risk of anaphylactic reactions
- Monitor for hypophosphataemia
- Caution in hepatic/renal impairment
Important Disclaimer
The Ferinject 50 mg/ 500 mg Solution for injection/infusion. professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
